Clinical Adoption Projection: Cardiac cytoprotective molecule under development in Israel:
26 Cardiologists from around the globe were selected for direct interview based on their peer reviewed publications and invited presentations.
Click above for an example from
a Strategy Inc. Clinical Adoption Projection
- Confirmation of the adoption cycle (both timing and level of financial commitment) is driven by the market perception of the product performance, and clinical need addressed by the technological solution. Best practices dictate at least initial discussions with a representative sampling of the potential target market.
- This process identifies therapeutic trends and practice patterns, instrumentation features, purchase decisions and cost considerations that influence a technology's selection.
- Critical to understand not only those technologies that a physician would be interested in performing a clinical trial with, but to understand the decision making behind their purchasing decisions. A Clinical Adoption Projection drives to this important difference.
- Clients consistently tell us that the Strategy Inc. Clinical Adoption Projection is surprisingly cost effective, and uncovered issues that became either market drivers, or circumvented what would have been a costly business mistake.
